Creative Medical Technology Holdings, Inc.
CELZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001187953
No open-market purchases or sales by Creative Medical Technology Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $540.7K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +4 vs. previous quarter
- 15
- 13F valueReported value at the end of Q2 2026
- $540.7K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding CELZ, Q2 2026
No superinvestor reported holding CELZ at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Creative Medical Technology Holdings, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2025 (view filing) | Feb 18-19 | 2 days | Finger Michael H.Director | SSale | −1.50K | $5.38 | −$8.06K | −81.0%351 after | 2 lots |
| Jun 29, 2023 (view filing) | Jun 27-28 | 2 days | Warbington TimothyPresident & CEO | PPurchase | +1.00K | $4.42 | +$4.42K | +8.9%12.2K after | 4 lots |
| Nov 23, 2022 (view filing)9:09 AM ET | Nov 21-22 | 2 days | Warbington TimothyPresident & CEO | PPurchase | +25.0K | $0.3945 | +$9.86K | +28.7%112.1K after | 4 lots |
| Sep 29, 2022 (view filing) | Sep 27 | 2 days | Finger Michael H.Director | PPurchase | +2.00K | $0.50 | +$1.00K | +12.1%18.5K after | |
| Sep 28, 2022 (view filing) | Sep 27 | 1 day | Warbington TimothyPresident & CEO | PPurchase | +20.0K | $0.50 | +$10.0K | +29.8%87.1K after | |
| Sep 22, 2022 (view filing) | Sep 21-22 | 1 day | Warbington TimothyPresident & CEO | PPurchase | +42.0K | $0.5935 | +$24.9K | +167.4%67.1K after | 5 lots |
| Jun 14, 2022 (view filing) | Jun 14 | Same day | Finger Michael H.Director | PPurchase | +10.0K | $0.70 | +$7.00K | +153.8%16.5K after | |
| Jun 7, 2022 (view filing) | Jun 6 | 1 day | Warbington TimothyPresident & CEO | PPurchase | +25.0K | $0.914 | +$22.9K | +28,735.6%25.1K after | 3 lots |
| May 20, 2022 (view filing) | May 20 | Same day | Finger Michael H.Director | PPurchase | +6.50K | $1.50 | +$9.75K | +325,000.0%6.50K after | |
| Jul 22, 2021 (view filing)8:54 PM ET | Jul 20-22 | 2 days | Ichim ThomasDirector | SSale | −4.35M | $0.0304 | −$132.4K | −49.0%4.53M after | 3 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Creative Medical Technology Holdings, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hudson Bay Capital Management LP | 135,170 | $196.0K | 0.00% | +135,170 | New |
| Anson Funds Management LP | 105,549 | $153.0K | 0.01% | +105,549 | New |
| Armistice Capital, LLC | 42,000 | $60.9K | 0.00% | +42,000 | New |
| XTX Topco Ltd | 26,559 | $38.5K | 0.00% | +12,299+86.2% | Added |
| Geode Capital Management, LLC | 25,799 | $37.4K | 0.00% | −12,491−32.6% | Reduced |
| Vanguard Capital Management LLC | 20,350 | $29.5K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 5,518 | $8.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,853 | $7.04K | 0.00% | +2,761+132.0% | Added |
| Global Retirement Partners, LLC | 4,118 | $5.97K | 0.00% | +4,118 | New |
| UBS Group AG | 2,061 | $2.99K | 0.00% | +2,060+206,000.0% | Added |